NCT02640118 - The Impact of Lixisenatide on Postprandial Glucose Tolerance in Pancreatectomised Subjects | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

August 31, 2015

Primary Completion Date

July 31, 2016

Study Completion Date

July 31, 2016

Conditions

Diabetes After Total Pancreatectomy

Interventions

DRUG

Lixisenatide

single injection of 20 µg lixisenatide subcutaneously

DRUG

Lixisenatide-Placebo

OTHER

Standardized liquid meal

standardized liquid meal (200 ml containing 1,650 kJ (394 kcal): carbohydrate 50%, protein 15%, fat 35%, consisting of glucose (48.4 g + 1.6 g \[U-13C6\]-glucose), rapeseed oil (14.1 g), whey protein (15.2 g) and 1.5 g paracetamol).